Rare Genomics Institute announces new director and CEO

The Rare Genomics Institute — a nonprofit in Hanover, Md., that connects rare disease patients with research technology and experts — has announced Paul Schindler as its new executive director and CEO.

Advertisement

Mr. Schindler has more than 10 years of experience in community development and nearly 20 years in entrepreneurship.

Prior to joining the Rare Genomics Institute, Mr. Schindler served as vice president of operations for Kreiger Consulting. He was also the founder, president and CEO of Living Hope Community Partnership, a community organization that helped families dealing with human trafficking, child hunger and other issues.

 

More articles on genomics:
Increased genomic testing drives need for more efficient data storage
NorthShore University HealthSystem launches Pharmacogenomics Clinic
Researchers to use ‘Internet of genomics’ to treat orphan diseases

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

  • Dale Neely will leave his role as CEO of HCA Florida Capital Hospital in Tallahassee, effective Oct. 23, HCA Healthcare…

  • Minal Vahora has been named CFO of Saint Francis Hospital in Evanston, Ill., part of Ontario, Calif.-based Prime Healthcare, according…

Advertisement

Comments are closed.